Cite

HARVARD Citation

    Macbeth, F. et al. (2022). Stereotactic Ablative Radiotherapy for Oligometastatic Disease: Great Enthusiasm but Scant Evidence. Clinical oncology. 34 (5), pp. 313-317. [Online]. 
  
Back to record